Trevi Therapeutics TRVI
NASDAQ TRVI
$14.18 -0.14 (-0.98%)
At close: Oct 1, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Times Interest Earned (2018 - 2022)

Updated

Trevi Therapeutics' (TRVI) Times Interest Earned was -12881.00 for FY2024, compared with -86.76 in FY2023.

Analysis

Trevi Therapeutics (TRVI) Times Interest Earned (2018 - 2022) Analysis & Trends

Dating back to FY2018, Trevi Therapeutics' Times Interest Earned record includes 6 years.

  • The FY2024 figure ranks as the lowest annual Times Interest Earned in data going back to FY2018.
  • According to Business Quant data, Times Interest Earned came in at -86.76 in FY2023, -25.72 in FY2022, -27.02 in FY2021 and -71.25 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Trevi Therapeutics 2.04 Bn 2.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -24.30
Sep 30, 2022 -28.78
Jun 30, 2022 -26.51
Mar 31, 2022 -23.26
Dec 31, 2021 -26.77
Sep 30, 2021 -22.93
Jun 30, 2021 -30.97
Mar 31, 2021 -27.51
Dec 31, 2020 -29.85
Sep 30, 2020 -48.95
Jun 30, 2018 -85.88
Mar 31, 2018 -25.54
API Access

Trevi Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=TRVI&period=max&api_key=YOUR_API_KEY